Scribe Therapeutics Statistics
Total Valuation
SCTX has a market cap or net worth of $536.50 million. The enterprise value is $533.10 million.
| Market Cap | 536.50M |
| Enterprise Value | 533.10M |
Important Dates
The next estimated earnings date is Friday, September 11, 2026, after market close.
| Earnings Date | Sep 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SCTX has 18.86 million shares outstanding.
| Current Share Class | 18.86M |
| Shares Outstanding | 18.86M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +1.79% |
| Owned by Insiders (%) | 8.83% |
| Owned by Institutions (%) | 2.07% |
| Float | 6.82M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 14.79 |
| Forward PS | 50.10 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 14.69 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.66
| Current Ratio | 0.66 |
| Quick Ratio | 0.64 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -13.77 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 226.98% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $407,663 |
| Profits Per Employee | -$401,461 |
| Employee Count | 89 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.26M |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 52.20 |
| Average Volume (20 Days) | 223,059 |
Short Selling Information
The latest short interest is 284,711, so 1.51% of the outstanding shares have been sold short.
| Short Interest | 284,711 |
| Short Previous Month | 263,070 |
| Short % of Shares Out | 1.51% |
| Short % of Float | 4.17% |
| Short Ratio (days to cover) | 0.65 |
Income Statement
In the last 12 months, SCTX had revenue of $36.28 million and -$35.73 million in losses. Loss per share was -$14.64.
| Revenue | 36.28M |
| Gross Profit | -19.83M |
| Operating Income | -32.94M |
| Pretax Income | -36.99M |
| Net Income | -35.73M |
| EBITDA | -29.98M |
| EBIT | -32.94M |
| Loss Per Share | -$14.64 |
Balance Sheet
The company has $49.73 million in cash and $46.33 million in debt, with a net cash position of $3.40 million or $0.18 per share.
| Cash & Cash Equivalents | 49.73M |
| Total Debt | 46.33M |
| Net Cash | 3.40M |
| Net Cash Per Share | $0.18 |
| Equity (Book Value) | -38.38M |
| Book Value Per Share | -64.31 |
| Working Capital | -27.32M |
Cash Flow
In the last 12 months, operating cash flow was -$39.15 million and capital expenditures -$797,000, giving a free cash flow of -$39.94 million.
| Operating Cash Flow | -39.15M |
| Capital Expenditures | -797,000 |
| Depreciation & Amortization | 2.96M |
| Net Borrowing | n/a |
| Free Cash Flow | -39.94M |
| FCF Per Share | -$2.12 |
Margins
Gross margin is -54.65%, with operating and profit margins of -90.79% and -98.48%.
| Gross Margin | -54.65% |
| Operating Margin | -90.79% |
| Pretax Margin | -101.95% |
| Profit Margin | -98.48% |
| EBITDA Margin | -82.62% |
| EBIT Margin | -90.79% |
| FCF Margin | n/a |
Dividends & Yields
SCTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -6.66% |
| FCF Yield | -7.45% |
Analyst Forecast
The average price target for SCTX is $56.00, which is 96.91% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $56.00 |
| Price Target Difference | 96.91% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | -48.48% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SCTX has an Altman Z-Score of -5.37. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.37 |
| Piotroski F-Score | n/a |